JWJason M. Wagner

Jason M. Wagner

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jason M. Wagner has a total of 58 co-authors. Here are the top co-authors by number of shared publications:

  • Anthony M. Alleman

    Department of Radiological Sciences, University of Oklahoma Health Sciences Center, College of Medicine, P.O. Box 2690, Garrison Tower, Suite 4G4250, Oklahoma City, OK 73126, USA

    4 shared publications
  • Rachel D. Conrad

    Departments of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA

    2 shared publications
  • Aashka Patel

    College of Medicine, University of Oklahoma, Oklahoma City, OK

    1 shared publication
  • Austin J. McCullough

    College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA

    1 shared publication
  • Benjamin D. Levine

    1 shared publication
  • Bradley K. Lamprich

    1 shared publication

Latest Publications

  • Indirect Inguinal Hernia

    by Oscar Gonzalo Talledo Zevallos, Kayla M. Watkins, Jason M. Wagner, Laura E. Fischer

  • Top Cited Papers

    Ultrasonography of Superficial Soft-Tissue Masses: Society of Radiologists in Ultrasound Consensus Conference Statement

    by Jon A. Jacobson, William D. Middleton, Sandra J. Allison, Nirvikar Dahiya, Kenneth S. Lee, Benjamin D. Levine, David R. Lucas, Mark D. Murphey, Levon N. Nazarian, Geoffrey W. Siegel, et al.

    This consensus statement reviews the US features of superficial soft-tissue masses, classified as reliably benign, non-specific neoplastic, lymphadenopathy, or pseudomass, and provides appropriate ... The Society of Radiologists in Ultrasound convened a panel of specialists from radiology, orthopedic surgery, and pathology to arrive at a consensus regarding the management of superficial soft-tis...


  • Utility of Longitudinal Measurement of the Liver With Ultrasound in Comparison to Computed Tomography Liver Volume in Assessing Hepatomegaly

    by Devaki Shilpa Sudha Surasi, Sammer Jazbeh, Zachary S. Nicek, Rosemarie G. Zanabria, Richard T. Wells, Aashka Patel, Laith Alhyari, Jason M. Wagner

    The purpose of the study is to retrospectively compare the longitudinal measurement of the liver on ultrasound (US) with liver volume as measured on computed tomography (CT). This institutional review board–approved retrospective study with prospective image analysis included adult patients with US examinations of the liver and CT examinations of the abdomen performed within 2 weeks of each other from January 1, 2010, to April 30, 2016. We recorded the dome-to-tip longitudinal length measurement of the right lobe of the liver on the US study. The liver volume was calculated using manual 3-dimensional segmentation of the CT data set. Additional linear liver measurements and qualitative assessments were retrospectively made on the US and CT images. Hepatomegaly was defined as a liver volume 2000 mL or greater. The sample had 302 patients including 140 males and 162 females. Liver length measured on US had a moderate positive correlation with liver volume measured on CT, with a Pearson correlation coefficient of 0.7078. The optimum cutoff of liver length (US) was found to be 17 cm by Youden index, with a sensitivity of 76.0% and specificity of 73.4% for hepatomegaly. Additional linear measurements and qualitative assessments of the liver did not significantly improve the diagnosis of hepatomegaly. In conclusion, liver length measured with US has only a moderate correlation with liver volume. Commonly used US liver length maximum values of 16 to 18 cm produce a significant number of false-negatives and false-positives for the diagnosis of hepatomegaly.


  • Ultrasound

    by Jason M. Wagner

  • Ultrasound of Soft Tissue Masses and Fluid Collections

    by Jason M. Wagner, Kristin Rebik, Paul J. Spicer


  • Ultrasonography of Cervical Lymph Nodes

    by Jason M. Wagner, Anthony M. Alleman


  • Ultrasound‐Guided Fine‐Needle Aspiration With Optional Core Needle Biopsy of Head and Neck Lymph Nodes and Masses: Comparison of Diagnostic Performance in Treated Squamous Cell Cancer Versus All Other Lesions

    by Jason M. Wagner, Natosha Monfore, Austin J. McCullough, Lichao Zhao, Rachel D. Conrad, Greg A. Krempl, Anthony M. Alleman

    Objectives To evaluate the diagnostic performance of ultrasound (US)‐guided fine‐needle aspiration with optional core needle biopsy of head and neck lymph nodes and masses, with attention to differences between biopsy of treated squamous cell carcinoma (SCC) and biopsy of other lesions. Methods Institutional Review Board approval was obtained, and the need for consent was waived for this retrospective study. All 861 US‐guided biopsies of head and neck lymph nodes and masses performed between March 1, 2012, and May 16, 2016, were reviewed. Results Of the 861 biopsies, 53 targeted SCC with residual masses after treatment. The biopsy procedures yielded benign or malignant pathologic results in 71.7% (38 of 53) of treated SCC and 90.7% (733 of 808) of all other lesions (P < .001). A reference standard based on subsequent pathologic results or clinical and imaging follow‐up was established in 68.4% of procedures. In cases with benign or malignant biopsy results and a subsequent reference standard, the sensitivity values for malignancy were 87.5% (95% confidence interval, 64.0%–96.5%) in treated SCC and 98.3% (95% confidence interval, 96.0%–99.3%) in all other cases (P = .047), and the specificity values were 63.6% (95% confidence interval, 35.4%–84.8%) in treated SCC and 99.5% (95% confidence interval, 97.3%–99.9%) in all other cases (P < .001). There were no major complications related to the biopsy procedures. Conclusions Excluding treated SCC, US‐guided fine‐needle aspiration with optional core needle biopsy of head and neck lymph nodes and masses has excellent diagnostic performance. Needle biopsy of head and neck SCC with a residual mass after therapy has a high rate of nondiagnostic samples, suboptimal sensitivity, and poor specificity.


  • Fine‐needle aspiration with selective use of core needle biopsy of major salivary gland tumors

    by Erica B. Romano, Jason M. Wagner, Anthony M. Alleman, Lichao Zhao, Rachel D. Conrad, Greg A. Krempl

    Objectives: Preferential use of fine‐needle aspiration (FNA) versus core needle biopsy (CNB) for distinguishing benign from malignant major salivary gland tumors is highly debated. The main disadvantage of FNA is lower sensitivity, whereas arguments against CNB include use of a larger bore needle and greater risk of complications. The aim of this study is to evaluate our experience performing ultrasound‐guided (UG) FNA with selective use of CNB based on preliminary cytopathology, and to determine whether our preoperative diagnostic approach is more sensitive and specific than FNA alone—and at least as sensitive and specific as CNB alone.Study Design: Retrospective review of UG needle biopsy sampling of lesions arising in or around parotid and submandibular glands.Methods: Ultrasounds of 141 needle biopsies were identified. Patient/lesion/needle biopsy characteristics, preliminary cytopathology, final pathology, imaging studies, and subsequent clinical course and treatment were documented.Results: Needle biopsies performed according to our protocol provided results that guided clinical decision making in 125 of 135 cases, 92.6% (95% confidence interval [CI], 86.8%–96.4%) of the time. Using 41 cases that had histologic verification, sensitivity was 100% (95% CI, 79.6%–100%), and specificity was 92.3% (95% CI, 75.9%–97.9%) for detecting malignancy. We definitively characterized 120 lesions as benign (84) or malignant (36).Conclusion: Preoperative needle biopsy diagnoses allowed clinical management to progress 92.6% of the time. The protocol of FNA with selective use of CNB may potentially reduce patient exposure to risks associated with CNB without the tradeoff of lower sensitivity seen with FNA.Level of Evidence: 4. Laryngoscope, 127:2522–2527, 2017


  • Ultrasound Versus Computed Tomographic Guidance for Percutaneous Biopsy of Chest Lesions

    by Maha Jarmakani, Sean Duguay, Kermit Rust, Keri Conner, Jason M. Wagner

    Objectives: To compare ultrasound (US) versus computed tomography (CT) for primary guidance during needle biopsy of chest lesions.Methods: Institutional Review Board approval was obtained for this Health Insurance Portability and Accountability Act–compliant retrospective study, and the need for informed consent was waived. All US‐ and CT‐guided chest biopsy procedures performed between January 1, 2012, and October 15, 2014, at our institution were reviewed, and all procedures targeting peripheral intrathoracic and chest wall lesions were included. Axillary lesions, lung lesions without peripheral pleural contact, and mediastinal lesions without a transcutaneous US window were excluded. Radiologic, pathologic, and clinical records were reviewed.Results: Fifty‐five procedures with primary US guidance (23 lung, 6 pleural, 2 mediastinal, and 24 chest wall) and 130 CT procedures (88 lung, 10 pleural, 7 mediastinal, and 25 chest wall) were performed. Diagnostic samples were obtained in 98% (54 of 55) of US procedures and 87% (113 of 130) of CT procedures (P = .02). Pneumothorax requiring treatment occurred in 2% (1 of 55) of US procedures and 5% (7 of 130) of CT procedures (P = .25). Computed tomographic localization was used in 29% (16 of 55) of US procedures. Nevertheless, the average patient radiation dose was significantly less in US procedures (182 mGy‐cm) versus CT procedures (718 mGy‐cm; P< .01). The average procedure time was 40 minutes for US and 38 minutes for CT (P = .39). The average lesion size was 4.5 cm for US and 4.9 cm for CT (P = .14).Conclusions: During biopsy of peripheral intrathoracic lesions and chest wall lesions, primary US guidance resulted in a higher likelihood of a diagnostic sample and a decreased patient radiation dose compared with CT guidance.


  • Ultrasound‐Guided Transcutaneous Needle Biopsy of the Base of the Tongue and Floor of the Mouth From a Submental Approach

    by Jason M. Wagner, Rachel D. Conrad, Trinitia Y. Cannon, Anthony M. Alleman

    Limited data exist regarding the feasibility of ultrasound-guided transcutaneous biopsy of the base of the tongue and floor of the mouth. This retrospective study reviewed 8 cases with lesions in the base of the tongue or floor of the mouth that were biopsied by fine-needle aspiration. Core biopsy was also needed in 1 case. All biopsies were technically successful, and all yielded squamous cell carcinoma. One biopsy yielded a false-positive result, as subsequent resection yielded high-grade dysplasia with no invasion. The other biopsy results were considered true-positive based on subsequent pathologic examinations (2 cases) or clinical/imaging follow-up (5 cases). There were no significant complications associated with the biopsies.